Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Plasma cell 2Thoracic 1Other 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 463Neoplasms, Plasma Cell 81Lymphoma 75Leukemia 51Lymphoma, Non-Hodgkin 49Leukemia, Lymphocytic, Chronic, B-Cell 45Myelodysplastic Syndromes 43Immunoglobulin Light-chain Amyloidosis 42Leukemia, Myeloid, Acute 39Hodgkin Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Neoplasms 32Hematologic Neoplasms 31Breast Neoplasms 31Myeloproliferative Disorders 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Monoclonal Gammopathy of Undetermined Significance 28Smoldering Multiple Myeloma 25Lymphoma, Mantle-Cell 25Lymphoma, B-Cell, Marginal Zone 24Recurrence 23Burkitt Lymphoma 21Amyloidosis 21Prostatic Neoplasms 20Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Waldenstrom Macroglobulinemia 18Sezary Syndrome 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Influenza, Human × Plasma cell × Clear all
NCT02294487 2024-10-03

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Wake Forest University Health Sciences

Completed
19 enrolled
Plasma cell

Influenza, Human, Multiple Myeloma, Pneumonia

NCT02298816 2024-10-03

HMvax-Regist

Wake Forest University Health Sciences

Withdrawn
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Influenza, Human, Lymphocytosis, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Pneumonia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡